Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: A randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate
- 1 May 1997
- Vol. 49 (3) , 411-420
- https://doi.org/10.1016/s0090-4295(96)00496-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Orchiectomy and Nilutamide or Placebo as Treatment of Metastatic Prostatic Cancer in a Multinational Double-Blind Randomized TrialJournal of Urology, 1993
- Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer.Journal of Clinical Oncology, 1992
- Estramustine and Vinblastine: Use of Prostate Specific Antigen as a Clinical Trial End Point for Hormone Refractory Prostatic CancerJournal of Urology, 1992
- Evidence for a non-estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivoThe Prostate, 1992
- Uptake of Estramustine Phosphate (Estracyt) Metabolites in Prostatic CancerJournal of Urology, 1988
- A Comparison of the Effect of Diethylstilbestrol with Low Dose Estramustine Phosphate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Phase III Trial of the European Organization for Research on Treatment of CancerJournal of Urology, 1986
- Estramustine Phosphate Compared with Diethylstilbestrol A Randomized, Double-Blind, Crossover Trial for Stage D Prostate CancerAmerican Journal of Clinical Oncology, 1986
- Estramustine‐induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC‐3The Prostate, 1984